{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T19:17:36Z","timestamp":1793733456139,"version":"4.6.1"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T00:00:00Z","timestamp":1766361600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T00:00:00Z","timestamp":1766361600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100011789","name":"Department of Science and Technology of Jilin Province","doi-asserted-by":"publisher","award":["YDZJ202501ZYTS063"],"award-info":[{"award-number":["YDZJ202501ZYTS063"]}],"id":[{"id":"10.13039\/501100011789","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Jilin Province Health Science and Technology Capability Enhancement Projec"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Commun Biol"],"DOI":"10.1038\/s42003-025-09393-x","type":"journal-article","created":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T11:30:55Z","timestamp":1766403055000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["FSCN1 regulates TGF-\u03b2 signalling to promote esophageal squamous cell carcinoma metastasis via stabilizing THBS1 mRNA"],"prefix":"10.1038","volume":"8","author":[{"given":"Da","family":"Qin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yulu","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8083-3816","authenticated-orcid":false,"given":"Hongfei","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,22]]},"reference":[{"key":"9393_CR1","doi-asserted-by":"crossref","unstructured":"Bray, F. et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Ca Cancer J. Clin. 74, 229\u2013263 (2024).","DOI":"10.3322\/caac.21834"},{"key":"9393_CR2","doi-asserted-by":"crossref","unstructured":"Cummings, D. et al. Epidemiology, diagnosis, staging and multimodal therapy of esophageal and gastric tumors. Cancers 13, 582 (2021).","DOI":"10.3390\/cancers13030582"},{"key":"9393_CR3","doi-asserted-by":"publisher","first-page":"3939","DOI":"10.1007\/s00262-023-03566-5","volume":"72","author":"N Li","year":"2023","unstructured":"Li, N. & Sohal, D. Current state of the art: immunotherapy in esophageal cancer and gastroesophageal junction cancer. Cancer Immunol. Immunother. 72, 3939\u20133952 (2023).","journal-title":"Cancer Immunol. Immunother."},{"key":"9393_CR4","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1111\/nyas.13677","volume":"1434","author":"AS Borggreve","year":"2018","unstructured":"Borggreve, A. S. et al. Surgical treatment of esophageal cancer in the era of multimodality management. Ann. N. Y. Acad. Sci. 1434, 192\u2013209 (2018).","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"9393_CR5","doi-asserted-by":"publisher","first-page":"1766","DOI":"10.1159\/000493622","volume":"49","author":"J Li","year":"2018","unstructured":"Li, J. et al. FSCN1 promotes epithelial-mesenchymal transition through increasing Snail1 in ovarian cancer cells. Cell Physiol. Biochem 49, 1766\u20131777 (2018).","journal-title":"Cell Physiol. Biochem"},{"key":"9393_CR6","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1038\/nature08978","volume":"464","author":"L Chen","year":"2010","unstructured":"Chen, L., Yang, S., Jakoncic, J., Zhang, J. J. & Huang, X. Y. Migrastatin analogues target fascin to block tumour metastasis. Nature 464, 1062\u20131066 (2010).","journal-title":"Nature"},{"key":"9393_CR7","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1016\/j.jmb.2018.03.009","volume":"430","author":"J Huang","year":"2018","unstructured":"Huang, J. et al. Structural insights into the induced-fit inhibition of fascin by a small-molecule inhibitor. J. mol. biol. 430, 1324\u20131335 (2018).","journal-title":"J. mol. biol."},{"key":"9393_CR8","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.ygyno.2019.01.020","volume":"153","author":"S McGuire","year":"2019","unstructured":"McGuire, S. et al. Inhibition of fascin in cancer and stromal cells blocks ovarian cancer metastasis. Gynecol. Oncol. 153, 405\u2013415 (2019).","journal-title":"Gynecol. Oncol."},{"key":"9393_CR9","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1007\/s00109-020-01877-z","volume":"98","author":"S Montoro-Garc\u00eda","year":"2020","unstructured":"Montoro-Garc\u00eda, S. et al. Novel anti-invasive properties of a Fascin1 inhibitor on colorectal cancer cells. J. Mol. Med. 98, 383\u2013394 (2020).","journal-title":"J. Mol. Med."},{"key":"9393_CR10","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1007\/s00726-017-2398-1","volume":"49","author":"FM Zeng","year":"2017","unstructured":"Zeng, F. M. et al. Fascin phosphorylation sites combine to regulate esophageal squamous cancer cell behavior. Amino Acids 49, 943\u2013955 (2017).","journal-title":"Amino Acids"},{"key":"9393_CR11","doi-asserted-by":"publisher","first-page":"2554","DOI":"10.1002\/1878-0261.12555","volume":"13","author":"SN Shen","year":"2019","unstructured":"Shen, S. N. et al. Down-regulation of long noncoding RNA PVT1 inhibits esophageal carcinoma cell migration and invasion and promotes cell apoptosis via microRNA-145-mediated inhibition of FSCN1. Mol. Oncol. 13, 2554\u20132573 (2019).","journal-title":"Mol. Oncol."},{"key":"9393_CR12","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1016\/j.molmed.2018.03.008","volume":"24","author":"P Chatterji","year":"2018","unstructured":"Chatterji, P. & Rustgi, A. K. RNA binding proteins in intestinal epithelial biology and colorectal cancer. Trends Mol. Med 24, 490\u2013506 (2018).","journal-title":"Trends Mol. Med"},{"key":"9393_CR13","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1038\/s41590-017-0028-4","volume":"19","author":"M Turner","year":"2018","unstructured":"Turner, M. & D\u00edaz-Mu\u00f1oz, M. D. RNA-binding proteins control gene expression and cell fate in the immune system. Nat. immunol. 19, 120\u2013129 (2018).","journal-title":"Nat. immunol."},{"key":"9393_CR14","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1016\/j.cell.2012.04.031","volume":"149","author":"A Castello","year":"2012","unstructured":"Castello, A. et al. Insights into RNA biology from an atlas of mammalian mRNA-binding proteins. Cell 149, 1393\u20131406 (2012).","journal-title":"Cell"},{"key":"9393_CR15","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.16526","volume":"11","author":"Q Sun","year":"2023","unstructured":"Sun, Q. et al. Fascin actin-bundling protein 1 regulates non-small cell lung cancer progression by influencing the transcription and splicing of tumorigenesis-related genes. PeerJ 11, e16526 (2023).","journal-title":"PeerJ"},{"key":"9393_CR16","doi-asserted-by":"publisher","first-page":"868296","DOI":"10.3389\/fphar.2022.868296","volume":"13","author":"H Cai","year":"2022","unstructured":"Cai, H., Wang, R., Tang, Z., Lu, T. & Cui, Y. FSCN1 promotes esophageal carcinoma progression through downregulating PTK6 via its RNA-binding protein effect. Front. Pharm. 13, 868296 (2022).","journal-title":"Front. Pharm."},{"key":"9393_CR17","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1016\/S0092-8674(00)81460-9","volume":"93","author":"SE Crawford","year":"1998","unstructured":"Crawford, S. E. et al. Thrombospondin-1 is a major activator of TGF-beta1 in vivo. Cell 93, 1159\u20131170 (1998).","journal-title":"Cell"},{"key":"9393_CR18","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/nrc2853","volume":"10","author":"H Ikushima","year":"2010","unstructured":"Ikushima, H. & Miyazono, K. TGFbeta signalling: a complex web in cancer progression. Nat. Rev. Cancer 10, 415\u2013424 (2010).","journal-title":"Nat. Rev. Cancer"},{"key":"9393_CR19","doi-asserted-by":"publisher","first-page":"95","DOI":"10.3892\/ol.2013.1650","volume":"7","author":"J Zhang","year":"2014","unstructured":"Zhang, J. et al. Correlation between TSP-1, TGF-\u03b2 and PPAR-\u03b3 expression levels and glioma microvascular density. Oncol. Lett. 7, 95\u2013100 (2014).","journal-title":"Oncol. Lett."},{"key":"9393_CR20","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.1158\/1535-7163.MCT-09-0122","volume":"8","author":"MK McElroy","year":"2009","unstructured":"McElroy, M. K. et al. Upregulation of thrombospondin-1 and angiogenesis in an aggressive human pancreatic cancer cell line selected for high metastasis. Mol. Cancer Ther. 8, 1779\u20131786 (2009).","journal-title":"Mol. Cancer Ther."},{"key":"9393_CR21","first-page":"178","volume":"1765","author":"B Ren","year":"2006","unstructured":"Ren, B., Yee, K. O., Lawler, J. & Khosravi-Far, R. Regulation of tumor angiogenesis by thrombospondin-1. Biochim Biophys. Acta 1765, 178\u2013188 (2006).","journal-title":"Biochim Biophys. Acta"},{"key":"9393_CR22","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1002\/cac2.12221","volume":"41","author":"YW Cheng","year":"2021","unstructured":"Cheng, Y. W. et al. P300\/CBP-associated factor (PCAF)-mediated acetylation of Fascin at lysine 471 inhibits its actin-bundling activity and tumor metastasis in esophageal cancer. Cancer Commun. 41, 1398\u20131416 (2021).","journal-title":"Cancer Commun."},{"key":"9393_CR23","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.matbio.2017.12.009","volume":"68-69","author":"JE Murphy-Ullrich","year":"2018","unstructured":"Murphy-Ullrich, J. E. & Suto, M. J. Thrombospondin-1 regulation of latent TGF-\u03b2 activation: a therapeutic target for fibrotic disease. Matrix biol. 68-69, 28\u201343 (2018).","journal-title":"Matrix biol."},{"key":"9393_CR24","doi-asserted-by":"publisher","first-page":"939","DOI":"10.2353\/ajpath.2010.090118","volume":"176","author":"JJ Xie","year":"2010","unstructured":"Xie, J. J. et al. Involvement of CYR61 and CTGF in the fascin-mediated proliferation and invasiveness of esophageal squamous cell carcinomas cells. Am. J. Pathol. 176, 939\u2013951 (2010).","journal-title":"Am. J. Pathol."},{"key":"9393_CR25","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1007\/s10555-012-9375-7","volume":"31","author":"Y Drabsch","year":"2012","unstructured":"Drabsch, Y. & ten Dijke, P. TGF-\u03b2 signalling and its role in cancer progression and metastasis. Cancer Metastasis Rev. 31, 553\u2013568 (2012).","journal-title":"Cancer Metastasis Rev."},{"key":"9393_CR26","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.cellsig.2018.09.002","volume":"52","author":"A Vander Ark","year":"2018","unstructured":"Vander Ark, A., Cao, J. & Li, X. TGF-\u03b2 receptors: in and beyond TGF-\u03b2 signaling. Cell signal 52, 112\u2013120 (2018).","journal-title":"Cell signal"},{"key":"9393_CR27","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1053\/j.gastro.2022.05.054","volume":"163","author":"E Morgan","year":"2022","unstructured":"Morgan, E. et al. The global landscape of esophageal squamous cell carcinoma and esophageal adenocarcinoma incidence and mortality in 2020 and projections to 2040: new estimates from GLOBOCAN 2020. Gastroenterology 163, 649\u2013658.e642 (2022).","journal-title":"Gastroenterology"},{"key":"9393_CR28","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/1759-7714.14745","volume":"14","author":"CQ Liu","year":"2023","unstructured":"Liu, C. Q. et al. Epidemiology of esophageal cancer in 2020 and projections to 2030 and 2040. Thorac. cancer 14, 3\u201311 (2023).","journal-title":"Thorac. cancer"},{"key":"9393_CR29","doi-asserted-by":"publisher","first-page":"2528","DOI":"10.7150\/jca.67977","volume":"13","author":"Z Li","year":"2022","unstructured":"Li, Z. et al. FSCN1 acts as a promising therapeutic target in the blockade of tumor cell motility: a review of its function, mechanism, and clinical significance. J. Cancer 13, 2528\u20132539 (2022).","journal-title":"J. Cancer"},{"key":"9393_CR30","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.omto.2020.12.014","volume":"20","author":"H Liu","year":"2021","unstructured":"Liu, H. et al. Fascin actin-bundling protein 1 in human cancer: promising biomarker or therapeutic target? Mol. Ther. Oncolytics 20, 240\u2013264 (2021).","journal-title":"Mol. Ther. Oncolytics"},{"key":"9393_CR31","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1016\/j.ceb.2004.07.009","volume":"16","author":"JC Adams","year":"2004","unstructured":"Adams, J. C. Roles of fascin in cell adhesion and motility. Curr. opin. cell biol. 16, 590\u2013596 (2004).","journal-title":"Curr. opin. cell biol."},{"key":"9393_CR32","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1002\/bies.10070","volume":"24","author":"N Kureishy","year":"2002","unstructured":"Kureishy, N., Sapountzi, V., Prag, S., Anilkumar, N. & Adams, J. C. Fascins, and their roles in cell structure and function. Bioessays 24, 350\u2013361 (2002).","journal-title":"Bioessays"},{"key":"9393_CR33","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1111\/febs.15484","volume":"288","author":"S Lin","year":"2021","unstructured":"Lin, S., Taylor, M. D., Singh, P. K. & Yang, S. How does fascin promote cancer metastasis? FEBS J. 288, 1434\u20131446 (2021).","journal-title":"FEBS J."},{"key":"9393_CR34","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1002\/path.6261","volume":"263","author":"DJ Li","year":"2024","unstructured":"Li, D. J. et al. KAT8\/SIRT7-mediated Fascin-K41 acetylation\/deacetylation regulates tumor metastasis in esophageal squamous cell carcinoma. J. Pathol. 263, 74\u201388 (2024).","journal-title":"J. Pathol."},{"key":"9393_CR35","doi-asserted-by":"publisher","DOI":"10.1002\/advs.201901380","volume":"7","author":"C Ou","year":"2020","unstructured":"Ou, C. et al. Targeting YAP1\/LINC00152\/FSCN1 signaling axis prevents the progression of colorectal cancer. Adv. Sci. 7, 1901380 (2020).","journal-title":"Adv. Sci."},{"key":"9393_CR36","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1186\/s13046-018-0850-z","volume":"37","author":"J Shen","year":"2018","unstructured":"Shen, J. et al. Hippo component YAP promotes focal adhesion and tumour aggressiveness via transcriptionally activating THBS1\/FAK signalling in breast cancer. J. Exp. Clin. Cancer Res. 37, 175 (2018).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"9393_CR37","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1186\/s13046-018-0815-2","volume":"37","author":"M Xiao","year":"2018","unstructured":"Xiao, M., Zhang, J., Chen, W. & Chen, W. M1-like tumor-associated macrophages activated by exosome-transferred THBS1 promote malignant migration in oral squamous cell carcinoma. J. Exp. Clin. Cancer Res. 37, 143 (2018).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"9393_CR38","doi-asserted-by":"crossref","unstructured":"Kaur, S. et al. Functions of thrombospondin-1 in the tumor microenvironment. Int. J. Mol. Sci. 22, 4570 (2021).","DOI":"10.3390\/ijms22094570"},{"key":"9393_CR39","doi-asserted-by":"publisher","first-page":"3503","DOI":"10.1016\/j.apsb.2022.07.012","volume":"13","author":"Q Xiao","year":"2023","unstructured":"Xiao, Q. et al. Improving cancer immunotherapy via co-delivering checkpoint blockade and thrombospondin-1 downregulator. Acta Pharm. Sin. B 13, 3503\u20133517 (2023).","journal-title":"Acta Pharm. Sin. B"},{"key":"9393_CR40","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-9-291","volume":"9","author":"ZQ Zhou","year":"2009","unstructured":"Zhou, Z. Q. et al. Expression and prognostic significance of THBS1, Cyr61 and CTGF in esophageal squamous cell carcinoma. BMC Cancer 9, 291 (2009).","journal-title":"BMC Cancer"},{"key":"9393_CR41","doi-asserted-by":"publisher","first-page":"75881","DOI":"10.18632\/oncotarget.17427","volume":"8","author":"C Hu","year":"2017","unstructured":"Hu, C. et al. Thrombospondin-1 promotes cell migration, invasion and lung metastasis of osteosarcoma through FAK dependent pathway. Oncotarget 8, 75881\u201375892 (2017).","journal-title":"Oncotarget"},{"key":"9393_CR42","doi-asserted-by":"publisher","first-page":"5782","DOI":"10.18632\/oncotarget.2164","volume":"5","author":"A Jayachandran","year":"2014","unstructured":"Jayachandran, A. et al. Thrombospondin 1 promotes an aggressive phenotype through epithelial-to-mesenchymal transition in human melanoma. Oncotarget 5, 5782\u20135797 (2014).","journal-title":"Oncotarget"},{"key":"9393_CR43","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1002\/hep.30657","volume":"70","author":"HD Yang","year":"2019","unstructured":"Yang, H. D. et al. HDAC6 suppresses Let-7i-5p to elicit TSP1\/CD47-mediated anti-tumorigenesis and phagocytosis of hepatocellular carcinoma. Hepatology 70, 1262\u20131279 (2019).","journal-title":"Hepatology"},{"key":"9393_CR44","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1007\/s00726-022-03193-x","volume":"54","author":"L Nan","year":"2022","unstructured":"Nan, L. et al. The post-translational modification of Fascin: impact on cell biology and its associations with inhibiting tumor metastasis. Amino Acids 54, 1541\u20131552 (2022).","journal-title":"Amino Acids"},{"key":"9393_CR45","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1186\/s13046-022-02551-7","volume":"41","author":"C Jin","year":"2022","unstructured":"Jin, C. et al. Acetyltransferase NAT10 regulates the Wnt\/\u03b2-catenin signaling pathway to promote colorectal cancer progression via ac(4)C acetylation of KIF23 mRNA. J. Exp. Clin. Cancer Res. 41, 345 (2022).","journal-title":"J. Exp. Clin. Cancer Res."}],"container-title":["Communications Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s42003-025-09393-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-025-09393-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-025-09393-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T13:02:05Z","timestamp":1766408525000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s42003-025-09393-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,22]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["9393"],"URL":"https:\/\/doi.org\/10.1038\/s42003-025-09393-x","relation":{},"ISSN":["2399-3642"],"issn-type":[{"value":"2399-3642","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,22]]},"assertion":[{"value":"6 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1805"}}